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Abstract: A simple, efficient and stereospecific approach for the
homologation of urethane-protected a-amino acids to b-amino
acids by the Arndt–Eistert method employing Fmoc-/Boc-a-amino
acid and 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyl-uronium
hexafluorophosphate mixture for the acylation of diazomethane
synthesizing the key intermediates Fmoc-/Boc-
a-aminodiazomethanes as crystalline solids is described.
Abbreviations: DCC, dicyclohexyl-carbodiimide; DCU,
dicyclohexylurea; HBTU, 2-(1H-benzotriazole-1-yl)-1,1,3,3-
tetramethyl-uronium hexafluorophosphate; DIEA,
N-ethyldiisopropylamine; NMM, N-methylmorpholine; NMP,
N-methyl-2-pyrrolidinone; TLC, thin-layer chromatography;
RP-HPLC, reverse phase-high-performance liquid chromatography.
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The oligomers comprising only b-amino acids (b-peptides)
have been in limelight in recent years (1–3). The incorpor-
ation of b-amino acid moieties in peptide sequences led to
obtain not only stable secondary structures but also found
to have the resistance to degradation by proteases (4).
b-Peptides are also finding increasing utility in the de novo
design of biologically active peptides such as amphiphilic
amino acid toxins, antibiotics, etc (5). Moreover, it has also
been found that an analog of HIV Tat 47–57 segment
comprising only b-amino acid units (HY-HG-HR-HK-HK-
HR-HR-HQ-HR-HR-HR) is found to translocate across
human cell membranes with efficiency comparable with
230
Tat 47–57 itself (6). In view of the spurt in the utility of
b-amino acids in both molecular design (7) as well as in
terms of the biologic significance (8), there is a need to
develop simple and efficient approaches for their synthesis.
The synthesis of b-amino acids through the homologa-
tion of Na-protected commercially available, optically
active, crystalline a-amino acids by the Arndt–Eistert
approach is a two step process involving the preparation of
Na-protected aminodiazomethane derivatives as key inter-
mediates (9). The mixed anhydride method, although
reported to be not ideally suited to amino acids bearing an
Fmoc group (10,11), is now routinely employed under
careful conditions with moderate yields (12,13). The acid
chloride method, although not applicable in Boc chem-
istry, has been found to be useful in the synthesis of
Fmoc-aminodiazomethane derivatives by Leggio et al. Our
group demonstrated the utility of both acid fluorides (14)
and pentafluorophenyl esters (15,16) which can be
employed in both Fmoc as well as Boc chemistries. The
latter approach was utilized by De Grado et al. (5,7), for
the synthesis of several b-amino acids including those
with side chain. On the other hand, the last decade has
witnessed the evolution of phosphonium and2 aminium
salts bearing HOBt/HOAt as new coupling agents (17,18).
They have been found to be very rapid, efficient, reliable
and useful for the synthesis of peptides with configura-
tional integrity.
2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyl-uronium
hexafluorophosphate (HBTU) (the aminium salt bearing
HOBt and tetramethylurea), introduced by Dourtoglou
et al. (19), is used routinely for the synthesis of peptides
in the presence of a tertiary amine like N-ethyldiisopro-
pylamine (DIEA), N-methylmorpholine (NMM), collidine,
etc. particularly for optimal efficiency (20). An impressive
example of its utility was demonstrated by Fisher and
Engelman for the synthesis of hydrophobic transmem-
brane – helices such as glycophorin A 69–101 segment
employing the Fmoc strategy (21). The coupling of sul-
folactosides to the aspartic acid moieties in the synthesis
of glycopeptides (22), the peptide nucleic acid (PNA)
oligomer synthesis (23), dimeric derivative of vancomycin
synthesis (24) are some of the other examples which
illustrate its utility for the difficult couplings. Above all,
it is nowadays commonly being employed as a coupling
agent in solid-phase peptide synthesis for rapid and effi-
cient synthesis with high yields and purity (25). Further,
availability and comparably less expensive than the other
related uronium and phosphonium reagents have made




afluorophosphate was purchased from Nova Biochem, CA,6
USA. Melting points were recorded on a capillary method
and are uncorrected. Optical rotations were measured on a7
AA-10 polarimeter (Optical Activity Ltd, Huntingdon, UK)
operating at the Sodium D line. Infra red spectra were
recorded on Nicolet model impact8 400D FT-IR spectrometer
(Thermo Nicolet Corp., Madison, WI, USA) (neat, CHCl3 as
solvent). TLC analysis was carried out using the solvent
systems: (i) chloroform : methanol : acetic acid :: 45 : 2 : 1,
(ii) ethyl acetate : hexane :: 35 : 65, (iii) chloroform :
methanol :: 9 : 1 and the Rf values are designated as RfA, RfB
and RfC, respectively. HPLC analysis was carried out with a9
Waters LC-3000 system (Waters Corp., Milford, MA, USA)
using a C18 Bondapack (3.9 · 300 mm, 10l) and chiralcel
OD (4.6 · 250 mm, 10l) columns with a linear gradient of
water (0.1% Trifluoroacetic acid (TFA)10 ) and acetonitrile
(0.1% TFA), with acetonitrile from 20 to 90% over 25 min.
1H NMR spectra were recorded on a11 Bruker AMX 400 MHz
spectrometer (Bruker, Zurich, Switzerland) using12 tetra-
methylsilane (TMS) as internal standard. The diazometh-
ane solution in dry ether was prepared from diazald using
reported procedure (26). The concentration of diazometh-
ane solution was estimated by back-titration using benzoic
acid solution (30).
General procedure for the preparation of
Na-protected aminoacyldiazomethanes
N-protected-a-amino acid (5 mmol) was dissolved in THF
: DMF mixture (2 : 1, 15 mL) and cooled to 0 C. After the
addition of HBTU (5 mmol) and DIEA (5.5 mmol, 1.1
equivalent) the mixture was stirred at 0 C for 5 min. The
resulting white suspension was allowed to warm up to
5 C and was treated with diazomethane in ether solution
(0.6 m, 25 mL). The reaction mixture was stirred at the
same temperature till the completion of the reaction and
evaporated in vacuo, dissolved the resulting residue in
dichloromethane, washed thrice using 5% HCl, 5%
NaHCO3 and brine, dried over anhydrous Na2SO4, and
concentrated under reduced pressure to give the title
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compound, which was recrystallized using appropriate
solvents.
Fmoc-l-phenylalanyldiazomethane (2a)
Light yellow solid; Yield 94%; m.p. 136 C; RfA 0.80; RfB
0.62; Anal. Calc. for C25H21N3O3 (411.44): C, 72.60; H, 5.60;
N, 10.16; Found: C, 72.35; H, 5.57; N, 9.78; IR cmax cm
)1
(neat, CHCl3): 2106 (CHN2);
1H NMR (d, CDCl3) : 2.62 (2H,
m), 4.25 (2H, m), 4.54 (2H, d), 5.3 (1H, s), 5.42 (1H, br) and
7.2–7.8 (13H, m).
Fmoc-l-phenylglycinyldiazomethane (2b)
Light yellow solid; Yield 90%; m.p. 148 C; RfA 0.81; RfB
0.62; Anal. Calc. for C24H19N3O3 (397.4): C, 72.50; H,
4.81; N, 10.57; Found: C, 72.68; H, 4.87; N, 10.6; IR cmax
cm)1 (neat, CHCl3): 2107 (CHN2);
1H NMR (d, CDCl3):
4.25 (2H, m), 4.45 (2H, d), 5.13 (1H, s), 6.0 (1H, br) and
7.2–7.8 (13H, m).
Fmoc-d-phenylglycinyldiazomethane (2c)
Light yellow solid; Yield 92%; m.p. 151 C; RfA 0.81; RfB
0.63; Anal. Calc. for C24H19N3O3 (397.4): C, 72.50; H,
4.81; N, 10.57; Found: C, 72.43; H, 4.90; N, 10.52; IR cmax
cm)1 (neat, CHCl3): 2106 (CHN2);
1H NMR (d, CDCl3):
4.22 (2H, m), 4.45 (2H, d), 5.1 (1H, s), 6.05 (1H, br) and
7.2–7.8 (13H, m).
Fmoc-l-aspartyl(OBut)diazomethane (2d)
Light yellow solid; Yield 86%; m.p. 73 C; RfA 0.82; RfB
0.67; Anal. Cal. for C24H25N3O5 (435.42): C, 66.20; H, 5.74;
N, 9.65; Found: C, 66.28; H, 5.64; N, 9.73; IR cmax cm
)1
(neat, CHCl3): 2105 (CHN2);
1H NMR (d, CDCl3): 1.42 (9H,
s), 2.0 (1H, m), 2.45 (2H, m), 4.32 (2H, d), 4.6 (1H, m), 5.42
(1H, s), 5.55 (1H, s) and 7.3–7.8 (8H, m).
Fmoc-l-glutamyl(OBut) diazomethane (2e)
Light yellow solid; Yield 85%; m.p. 136 C; RfA 0.83; RfB
0.68; Anal. Calc. for C25H27N3O5 (449.48): C, 66.80; H, 6.04;
N, 9.35; Found: C, 65.92; H, 6.28; N, 9.45; IR cmax cm
)1 (neat,
CHCl3): 2115 (CHN2);
1H NMR (d, CDCl3): 1.45 (9H, s), 1.8
(1H, m), 2.2 (1H, m), 2.45 (2H, m), 4.23 (2H, d), 4.35 (1H, br),
4.5 (1H, m), 5.42 (1H, s), 5.6 (1H, s) and 7.2–7.8 (8H, m).
Fmoc-l- lysyl( -Boc)diazomethane (2f)
Light yellow solid; Yield 90%; m.p. 96 C; RfA 0.74; RfB
0.60; Anal. Cal. for C27H32N4O5 (492.52): C, 65.8; H, 6.54;
N, 11.37; Found: C, 64.86; H, 6.64; N, 11.45; IR cmax cm
)1
(neat, CHCl3): 2108 (CHN2);
1H NMR (d, CDCl3): 1.42 (9H,
s), 2.25 (8H, m), 4.14 (2H, m), 4.25 (2H, d), 5.23 (1H, s), 5.62
(1H, br), 6.05 (1H, br) and 7.2–7.8 (8H, m).
Fmoc-l-serine(But) diazomethane (2g)
Gum; Yield 88%; RfA 0.76; RfB 0.62; Anal. Cal. for
C23H25N3O4 (407.43): C, 67.80; H, 6.18; N, 10.31; Found: C,
67.63; H, 6.43; N, 10.25; IR cmax cm
)1 (neat, CHCl3): 2106
(CHN2);
1H NMR (d, CDCl3): 1.2 (9H, s), 3.45 (1H, d), 3.8
(1H, m), 4.2 (1H, t), 4.3 (1H, br), 4.45 (2H, m), 5.4 (1H, s), 5.6
(1H, br) and 7.3–7.8 (8H, m).
Fmoc-l-valyldiazomethane (2h)
Yellow solid; Yield 94%; m.p. 123–124 C; RfA 0.81; RfB
0.69; Anal. Cal. for C21H21N3O3 (365.42): C, 69.41; H, 5.81;
N, 11.56; Found: C, 69.48; H, 5.84; N, 11.65; IR cmax cm
)1
(neat, CHCl3): 2106 (CHN2);
1H NMR (d, CDCl3): 0.90 (3H,
d), 1.10 (3H, d), 2.15 (1H, m), 4.10 (1H, m), 4.25 (1H, m), 4.4
(2H, m), 5.25 (1H, s), 5.4 (1H, d) and 7.3–7.8 (8H, m).
Boc-alanyldiazomethane (2i)
Yellow solid; Yield 93%; m.p. 82 C; RfA 0.82; RfB 0.72;
Anal. Calc. for C9H15N3O3 (213.22): C, 50.69; H, 7.08; N,
19.70; Found: C, 50.80; H, 7.20; N, 19.47; IR cmax cm
)1
(neat, CHCl3): 2104 (CHN2);
1H NMR (d, CDCl3): 1.05 (3H,
d), 1.32 (9H, s), 4.21 (1H, m), 5.25 (1H, s) and 5.5 (1H, br).
Boc-l-isoleucyldiazomethane (2j)
Yellow solid; Yield 88%; m.p. 85–86 C; RfA 0.73; RfB 0.60;
Anal. Cal. for C11H21N3O3 (255.28): C, 56.45; H, 8.28; N,
16.45; Found: C, 56.28; H, 8.34; N, 16.48; IR cmax cm
)1
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(neat, CHCl3): 2107 (CHN2);
1H NMR (d, CDCl3): 0.9 (6H,
m), 1.32 (11H, m), 1.5 (1H, m), 4.24 (1H, m), 5.3 (1H, s) and
5.42 (1H, br).
General procedure for the synthesis of
N-protected-b-homoamino acids
Na-protected aminoacyldiazomethane (5 mmol) in
1,4-dioxane (15 mL) and water (10 mL) was treated with
silver benzoate (20 mg, 0.08 mmol). It was refluxed at
70 C for about 4–5 h and then filtered. The solvent was
evaporated under reduced pressure. The residue was dis-
solved in saturated aqueous Na2CO3 solution (50 mL) and
stirred. The resulting solution was washed with ether
(3 · 30 mL). The aqueous layer was acidified to pH 2
using HCl (for Fmoc-b-homoamino acid) or citric acid (for
Boc-b-homoamino acid) and extracted with ethyl acetate
(3 · 30 mL). The organic layer was washed with water,
dried over anhydrous Na2SO4 and evaporated to get the
title compound.
After the isolation of each Fmoc-/Boc-a-aminoacyldiazo-
methane derivative, their IR analysis was carried out to find
out the presence of Fmoc-/Boc-a-amino acid methyl ester
(the peak at around 1745 cm)1, characteristic of CO
stretching vibrational frequency of methyl ester). If the
methyl ester is present in any batch, then, the resulting
product has been converted to the corresponding b-amino
acid following the above general procedure. After the rear-
rangement, the product was dissolved in aqueous sodium
carbonate solution and washed thoroughly with ether for
several times. This will ensure the complete removal of
Fmoc-/Boc-a-amino acid methyl ester.
Fmoc-l-b-homophenylalanine (3a)
White solid; Yield 85%; m.p. 110 C; RfA 0.63; RfC
0.75; Anal. Calc. for C25H23NO4 (401.42): C, 75.05; H,
5.58; N, 3.70; Found: C, 75.21; H, 5.46; N, 3.80; 1H NMR
(d, CDCl3): 2.42 (1H, d), 2.50 (2H, m), 2.73 (1H, d), 3.63
(1H, m), 4.15 (1H, m), 4.22 (2H, m),6.0 (1H, m) and 7.3–7.8
(13H, m).
Fmoc-b-homophenylglycine (3b)
White solid; Yield 82%; m.p. 97 C; RfA 0.61; RfC 0.78;
Anal. Calc. for C24H21NO4 (387.41): C, 74.40; H, 5.45; N,
3.61; Found: C, 74.26; H, 5.23; N, 3.80; 1H NMR (d, CDCl3):
2.5 (2H, d), 4.23 (2H, m), 4.45 (2H, d), 5.85 (1H, br), 6.2 (1H,
br) and 7.3–7.8 (13H, m).
Fmoc-b-d-homophenylglycine (3c)
White solid; Yield 84%; m.p. 98 C; RfA 0.62; RfC 0.78;
Anal. Calc. for C24H21NO4 (387.41): C, 74.40; H, 5.45; N,
3.61; Found: C, 74.34; H, 5.16; N, 3.76; 1H NMR (d, CDCl3):
2.45 (2H, d), 4.2 (2H, m), 4.32 (2H, d), 5.80 (1H, br), 6.25 (1H,
br) and 7.2–7.8 (13H, m).
Fmoc-l-b-homoaspartic acid (OBut) (3d)
White solid; Yield 79%; m.p. 84–85 C; RfA 0.70; RfC 0.82;
Anal. Cal. for C24H27NO6 (425.41): C, 67.76; H, 6.35; N,
3.29; Found: C, 67.64; H, 6.48; N, 3.43; 1H NMR (d, CDCl3):
1.4 (9H, s), 2.6 (4H, m), 4.3 (4H, m), 6.53 (1H, br) and 7.2–7.8
(8H, m).
Fmoc-l-b-homoglutamic acid (OBut) (3e)
White solid; Yield 78%; m.p. 57–58 C; RfA 0.71; RfC 0.83;
Anal. Calc. for C25H29 NO6 (439.48): C, 68.33; H, 6.64; N,
3.18; Found: C, 68.52; H, 6.48; N, 3.26; 1H NMR (d, CDCl3):
1.42 (9H, s), 2.4 (4H, m), 3.8–4.0 (4H, m), 4.25 (2H, m), 5.65
(1H, d) and 7.2–7.8 (8H, m).
Fmoc-l-b-(-Boc)homolysine (3f)
White solid; Yield 75%; m.p. 96 C; RfA 0.68; RfC 0.80;
Anal. Cal. for C27H34N2O6 (482.52): C, 64.6; H, 6.53; N,
5.38; Found: C, 64.42; H, 6.48; N, 5.32; 1H NMR (d, CDCl3):
1.45 (9H, s), 2.2 (8H, m), 2.32 (1H, d), 2.45 (2H, d), 4.12 (3H,
m), 5.65 (1H, br) and 7.25–7.8 (9H, m).
Fmoc-l-b-homoserine (But) (3g)
White solid; Yield 74%; m.p. 98–99 C; RfA 0.64; RfC 0.76;
Anal. Calc. for C23H27NO5 (397.44): C, 69.50; H, 6.84; N,
3.52; Found: C, 69.38; H, 6.56; N, 3.84; 1H NMR (d, CDCl3):
1.15 (9H, s), 2.6 (1H, d), 2.72 (1H, d), 3.42 (1H, m), 3.5 (1H,
m), 4.12 (1H, m), 4.25 (2H, m), 4.30 (1H, m), 6.2 (1H, br) and
7.2–7.8 (8H, m).
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Fmoc-l-b-homovaline (3h)
White solid; Yield 78%; m.p. 97–98 C; RfA 0.66; RfC 0.78;
Anal. Calc. for C21H23NO4 (353.38): C, 70.14; H, 5.89; N,
4.30; Found: C, 70.28; H, 5.65; N, 4.32; 1H NMR (d, CDCl3):
0.9 (6H, d), 1.8 (1H, m), 2.32 (1H, d), 2.45 (1H, d), 3.8 (1H, m),
4.3 (3H, m), 5.65 (1H, m) and 7.3–7.8 (8H, m).
Boc-l-b-homoalanine (3i)
White solid; Yield 88%; m.p. 99 C; RfA 0.66; RfC 0.72;
Anal. Calc. for C9H17NO4 (203.22): C, 53.45; H, 8.47; N,
6.92; Found: C, 53.28; H, 8.56; N, 6.56; 1H NMR (d, CDCl3):
1.2 (3H, d), 1.33 (9H, s), 2.4 (2H, d), 4.01 (1H, m) and 5.25
(1H, br).
Boc-l-b-homoisoleucine (3j)
White solid; Yield 80 %; m.p. 86 C; RfA 0.65; RfC 0.74;
Anal. Cal. for C12H23NO4 (245.28): C, 58.99; H, 9.48; N,
5.73; Found: C, 58.86; H, 9.56; N, 5.68; 1H NMR (d, CDCl3):
0.9 (6H, m), 1.32 (11H, m), 1.5 (1H, m), 2.35 (2H, d), 3.5 (1H,
m) and 5.4 (1H, br).
Results and Discussion
It is now found that the acylation of diazomethane can
be carried out using an equimolar mixture of Fmoc-/
Boc-a-amino acid, HBTU in tetrahydrofuran3 (THF) :
N,N-DimethylFormamide (DMF) (2 : 1, v/v) solution.
Diazomethane2 (264 ), generated using diazald (N-methyl-
N-nitroso-p-tolunesulfonamide), was passed into the cold
ether and then used. Prior to the addition of diazomethane
solution, to the solution of Fmoc-/Boc-a-amino acids in
THF, HBTU and DIEA solution in minimum amount of
DMF (instead of DMF, NMP can also be used) is added at
0 C and stirred for about 5 min. (Fig. 1) initially. And then,
the resulting reaction mixture was stirred till the comple-
15 Figure 1. Reagents and conditions for the synthesis of b-amino acids.
2The preparation of diazomethane should be carried out only in a fume
cupboard provided with a powerful exhaust system. The use of a screen of a
safety glass in addition to wearing safety spectacles is essential.
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tion of the reaction at the same temperature. As monitored
by thin-layer chromatography (TLC) as well as5 infra red (IR)
spectrum, it has been found that the acylation is complete
within 15–20 min. The completion of the reaction can be
observed visually by the disappearance of the yellow color
of the reaction mixture also. The resulting a-aminoacyldi-
azomethanes do not require any further purification. All the
Fmoc-/Boc-a-aminoacyldiazomethane derivatives 2 a–j
have been isolated as crystalline solids in good yield. The
purity of the compounds, as checked by RP-HPLC, was
satisfactory. They were easily identified using IR by the
presence of characteristic stretching vibrational frequencies
at around 2100 cm)1 (-CHN2 group) and 1640 cm
)1
(-COCHN2). When the reaction was carried out under
completely anhydrous conditions, the formation of the
corresponding methyl ester has been completely circum-
vented. Their presence, if any, can be easily detected by IR
(at 1745 cm)1, as a result of the carbonyl stretching
vibrational frequency of COOMe moiety). During the re-
peated preparation of Fmoc-/Boc-a-aminoacyldiazomethane
compounds required in large quantities for the studies
concern with the synthesis of b-peptides related to bio-
elastic pentamers VPGVG, PGVGV, GVGVP, VGVGP,
GVPGV, etc. (27) in some batches, a small quantity of the
formation of methyl ester of Fmoc-amino acid was also
noticed clearly in IR analysis. In such batches, the Fmoc-a-
aminoacyldiazomethane containing small quantity of
Fmoc-a-amino acid methyl ester was directly converted to
its b-amino acid by the Wolff rearrangement without any
purification. After the reaction, the unconverted Fmoc-a-
amino acid methyl ester could be easily removed by
extraction with ether.
All the resulting Fmoc-/Boc-a-aminoacyldiazomethanes 2
a–j were then converted to the corresponding b-amino acids
3 a–j using Wolff rearrangement employing silver benzoate,
1,4-dioxane and water mixture by refluxing for nearly 4–5 h.
The Fmoc-/Boc-b-amino acids were obtained as crystalline
solids and are fully characterized.
In order to study the stereospecificity of the reaction, the
determined specific rotations of 2b: [a]25D [c 1, CHCl3,
)32.3()32.0)] and 2c: [a]25D [c 1, CHCl3 + 32.8(+32.3)] and 3b:
[a]25D [c 1, CHCl3, )22.2()22.0)] and 3c: [a]
25
D [c 1, CHCl3,
+21.8(+21.8)] were compared (14). Further, the HPLC ana-
lysis of Fmoc-l-Val-DAM (Rt for l-isomer 17.48 min, Rt for
racemic mixture 17.44 and 18.18 min) and Fmoc-l-bHVal-
OH (Rt for l-isomer 15.42 min, Rt for racemic mixture
15.36 and 16.12 min), derived from Fmoc-l-Val-OH and
comparison with the analysis of racemic mixture specific-
ally prepared to test the possible extent of racemization
revealed that the homologation of a-amino acid to its
b-analog using HBTU is found to be free from racemization.
It has been demonstrated now that HBTU can be suc-
cessfully employed for the homologation of Fmoc-/Boc-a-
amino acids with good yield and without racemization. The
reaction is simple and can be easily scaled up for the pre-
paration of b-amino acid in large quantities. Unlike in the
case of dicyclohexyl-carbodiimide (DCC), HBTU is neither
irritant nor the separation of side products poses any prob-
lems. To the best of our knowledge, DCC is the only
coupling agent which has been used earlier so far for the
homologation of a-amino acids (28). Further, the use of
DCC for the homologation of Boc-/Pth-amino acids has
resulted in only about 35–70% yield of the corresponding
diazomethane derivative (29). In the present study, all the
diazomethane derivatives were obtained in 85–94% yield.
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